- Home
- HCI vs APGE Comparison
HCI vs APGE Comparison
Compare HCI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- APGE
- Stock Information
- Founded
- HCI 2006
- APGE 2022
- Country
- HCI United States
- APGE United States
- Employees
- HCI N/A
- APGE N/A
- Industry
- HCI Property-Casualty Insurers
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HCI Finance
- APGE Health Care
- Exchange
- HCI Nasdaq
- APGE Nasdaq
- Market Cap
- HCI 2.4B
- APGE 2.4B
- IPO Year
- HCI N/A
- APGE 2023
- Fundamental
- Price
- HCI $201.74
- APGE $56.38
- Analyst Decision
- HCI Strong Buy
- APGE Strong Buy
- Analyst Count
- HCI 4
- APGE 8
- Target Price
- HCI $181.25
- APGE $94.63
- AVG Volume (30 Days)
- HCI 169.7K
- APGE 934.2K
- Earning Date
- HCI 11-06-2025
- APGE 11-12-2025
- Dividend Yield
- HCI 0.79%
- APGE N/A
- EPS Growth
- HCI N/A
- APGE N/A
- EPS
- HCI 11.47
- APGE N/A
- Revenue
- HCI $775,545,000.00
- APGE N/A
- Revenue This Year
- HCI $19.75
- APGE N/A
- Revenue Next Year
- HCI $8.24
- APGE N/A
- P/E Ratio
- HCI $17.58
- APGE N/A
- Revenue Growth
- HCI 9.67
- APGE N/A
- 52 Week Low
- HCI $105.00
- APGE $26.20
- 52 Week High
- HCI $210.50
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- HCI 60.33
- APGE 69.88
- Support Level
- HCI $185.06
- APGE $51.80
- Resistance Level
- HCI $210.50
- APGE $57.34
- Average True Range (ATR)
- HCI 7.74
- APGE 3.14
- MACD
- HCI 0.15
- APGE 0.06
- Stochastic Oscillator
- HCI 68.24
- APGE 87.90
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.